article thumbnail

Injectable opportunities for CMOs despite internal capacity of big pharma sponsors

Pharmaceutical Technology

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Why do large and mega-cap sponsors outsource?

article thumbnail

Develop and execute a winning drug launch strategy with an experienced contract packager

Pharmaceutical Technology

Navigating the complexities of pharma and biotech packaging services can be difficult. Packaging trends The pharmaceutical contract packaging market is witnessing substantial growth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023

Pharmaceutical Technology

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

article thumbnail

Ocugen gets a black eye as FDA denies emergency OK for COVID jab

pharmaphorum

The Philadelphia-based company said it had taken the decision to go down the biologics license application (BLA) route for Covaxin based on FDA feedback to the EUA data package it had submitted to the agency.

article thumbnail

Guido Rasi steps down, handing the running of EMA to Emer Cooke

pharmaphorum

During his tenure the EMA also implemented new rules to encourage the development of advanced therapy medicinal products (ATMPs) like gene and cell therapies, and the introduction of the PRIME fast-track review for promising medicines. Emer Cooke.

article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. This looks like it may change shape in the future for the region, if the proposal put forward by the commission is adopted.

article thumbnail

Leading API biologics (cell, gene, vaccine and virus) companies in contract marketing

Pharmaceutical Technology

Pharmaceutical Technology has listed some of the top API biologics companies in contract marketing based on our intel, insights and decades-long experience in the sector. The post Leading API biologics (cell, gene, vaccine and virus) companies in contract marketing appeared first on Pharmaceutical Technology.

Gene 100